Sai Parenteral's Limited IPO
Pharmaceuticals · DRHP 30 Sept 2025 · listed 2 Apr 2026
Follow this IPOuse-of-proceeds reports, on Telegram
- Issue price
- ₹392.00
- band ₹372.00 to ₹392.00
- Fresh issue
- ₹285.0 cr
- plus any offer for sale
- Lot
- 38 shares
- ₹14,896 at the top of the band
- Subscription window
- 24 Mar to 27 Mar
- 2026
- Listing
- 2 Apr 2026
- NSE
- Subscribed
- 0.6x
- retail 0.1x
About the Sai Parenteral's IPO
Sai Parenteral's Limited raised money through a mainboard IPO on NSE and BSE: a fresh issue of ₹285 crore.
Bidding ran Tue 24 Mar to Fri 27 Mar, at an issue price of ₹392 a share, in lots of 38 shares. The shares listed on 2 Apr 2026.
The book-running lead manager is Arihant Capital Markets Limited. The registrar, which handles allotment, is Bigshare Services Private Limited.
The issue was subscribed 0.63 times overall, with the retail portion at 0.08 times, as the exchange's bid book showed.
The draft offer document was filed on 30 Sept 2025.
newboard writes its studies from the offer document before an issue lists, and this one listed without one. The figures on this page are the exchange's and the offer document's, each with its source.
Sai Parenteral's IPO: questions answered
When was the Sai Parenteral's IPO open, and what were the price band and lot size?
Bidding ran Tue 24 Mar to Fri 27 Mar. The issue price is ₹392 a share. One lot is 38 shares, ₹14,896 at the upper end of the band.
When did the Sai Parenteral's IPO list?
The shares listed on 2 Apr 2026 on NSE and BSE.
How do I check the Sai Parenteral's IPO allotment status?
Allotment is finalised by the registrar, Bigshare Services Private Limited, usually the working day after the issue closes. Check it on the registrar's website or on BSE and NSE with a PAN, application number or DP ID. Shares not allotted have their blocked amount released by the refund date.
The Sai Parenteral's IPO allotment status page, with the direct links
Who are the registrar and lead managers of the Sai Parenteral's IPO?
The book-running lead manager is Arihant Capital Markets Limited. The registrar, which handles applications and allotment, is Bigshare Services Private Limited.
How many times was the Sai Parenteral's IPO subscribed?
0.63 times overall, as the exchange's bid book last showed: qualified institutions 1.08 times, non-institutional investors 0.2 times and retail 0.08 times.
Is the Sai Parenteral's IPO a fresh issue or an offer for sale?
A fresh issue of ₹285 crore, which goes to the company.
What is the Sai Parenteral's IPO GMP?
newboard does not publish a grey-market premium. Grey-market deals happen outside the stock exchanges, are not regulated, and leave no public record of who traded at what price. What is on record is the offer document, read on this page, and the exchanges' bid book.
Where the money went
The monitoring agency's report for the quarter to 30 Jun 2026: each object in the offer document and how much of it had been used by then.
| Object | Proposed, ₹ crore | Used, ₹ crore |
|---|---|---|
| Capacity expansion and upgradation of manufacturing facilities Management Representation, Prospectus, Relevant | 180.2 | 0.0 |
| General Corporate Purposes | 447.4 | 189.9 |
| Repayment / prepayment of certain outstanding borrowings | 143.0 | 136.5 |
| Working capital requirements | 330.0 | 330.0 |
Sai Parenteral's IPO: the next step, on Telegram
A message when there is news on each use-of-proceeds report the company files. Free, no account, leave in one tap. Send /stop to end it.
Not on this page yet: an offer-document study, the peer table the issuer printed. Each is added when the pipeline extracts it from the offer document.
The figures on this page are the company's own, taken from its filings with the exchanges and SEBI, and every number links to the document and page it came from. They are reproduced as stated, not verified independently, and they are not forecasts by newboard.in. Nothing here is investment advice, a research report or a recommendation. newboard.in is not a SEBI-registered research analyst or investment adviser.